Related content

Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?

By Raitt Merritt  

Future Cardiology, Vol. 2, Iss. 3, 2006-05 ,pp. : 273-279

Future Medicine

Access to resources Recommend Favorite

New directions in antiarrhythmic drug therapy for atrial fibrillation

By Heijman Jordi   Voigt Niels   Dobrev Dobromir  

Future Cardiology, Vol. 9, Iss. 1, 2013-01 ,pp. : 71-88

Future Medicine

Access to resources Recommend Favorite

Future directions in antiarrhythmic drug therapy for atrial fibrillation

By Musco Simone   Seltzer Jonathan   Kowey Peter R  

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 545-553

Future Medicine

Access to resources Recommend Favorite

Risk Stratification by the “EPA+DHA Level” and the “EPA/AA Ratio”: Focus on Anti-Inflammatory and Antiarrhythmogenic Effects of Long-Chain Omega-3 Fatty Acids

By Rupp Heinz  

Herz, Vol. 29, Iss. 7, 2004-11 ,pp. : 673-685

Springer Publishing Company

Access to resources Recommend Favorite

Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease.

By Eritsland J.   Seljeflot I.   Arnesen H.   Westvik .-B.   Kierulf P.  

Thrombosis Research, Vol. 77, Iss. 4, 1995-02 ,pp. : 337-346

Elsevier

Access to resources Recommend Favorite